Precision Medicine Online

T-ALL Patients Treated With Base-Edited CAR7 T-Cell Therapy Enter Deep Remission, ASH Data Show

Of the 11 patients treated with BE-CAR7 T cells, seven are in remission, including one patient who has been in remission for three years.